[go: up one dir, main page]

NO20022689L - Antitrombotisk forbindelse - Google Patents

Antitrombotisk forbindelse

Info

Publication number
NO20022689L
NO20022689L NO20022689A NO20022689A NO20022689L NO 20022689 L NO20022689 L NO 20022689L NO 20022689 A NO20022689 A NO 20022689A NO 20022689 A NO20022689 A NO 20022689A NO 20022689 L NO20022689 L NO 20022689L
Authority
NO
Norway
Prior art keywords
antithrombotic compound
antithrombotic
compound
Prior art date
Application number
NO20022689A
Other languages
English (en)
Other versions
NO323059B1 (no
NO20022689D0 (no
Inventor
Constant Adriaan Anton Boeckel
Cornelia Maria Tromp
Tamara Theodora Maria Geertsen
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Publication of NO20022689L publication Critical patent/NO20022689L/no
Publication of NO20022689D0 publication Critical patent/NO20022689D0/no
Publication of NO323059B1 publication Critical patent/NO323059B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H3/00—Compounds containing only hydrogen atoms and saccharide radicals having only carbon, hydrogen, and oxygen atoms
    • C07H3/06—Oligosaccharides, i.e. having three to five saccharide radicals attached to each other by glycosidic linkages
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H1/00—Processes for the preparation of sugar derivatives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/26—Acyclic or carbocyclic radicals, substituted by hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/001—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence having less than 12 amino acids and not being part of a ring structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
NO20022689A 1999-12-07 2002-06-06 Antitrombotisk forbindelse, samt fremstilling og anvendelse derav og farmasoytisk preparat. NO323059B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP99204172 1999-12-07
PCT/EP2000/012155 WO2001042262A2 (en) 1999-12-07 2000-12-01 Antithrombotic compound

Publications (3)

Publication Number Publication Date
NO20022689L true NO20022689L (no) 2002-06-06
NO20022689D0 NO20022689D0 (no) 2002-06-06
NO323059B1 NO323059B1 (no) 2006-12-27

Family

ID=8240976

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20022689A NO323059B1 (no) 1999-12-07 2002-06-06 Antitrombotisk forbindelse, samt fremstilling og anvendelse derav og farmasoytisk preparat.

Country Status (23)

Country Link
US (1) US6875755B2 (no)
EP (1) EP1237897B1 (no)
JP (1) JP4820517B2 (no)
KR (1) KR100776607B1 (no)
CN (1) CN1195767C (no)
AR (1) AR026726A1 (no)
AU (1) AU781846B2 (no)
BR (1) BR0016217A (no)
CA (1) CA2393042C (no)
CO (1) CO5251449A1 (no)
CZ (1) CZ303385B6 (no)
HK (1) HK1047593A1 (no)
HU (1) HUP0203471A3 (no)
IL (2) IL149628A0 (no)
NO (1) NO323059B1 (no)
NZ (1) NZ519100A (no)
PE (1) PE20010935A1 (no)
PL (1) PL202840B1 (no)
RU (1) RU2266913C2 (no)
SK (1) SK287682B6 (no)
TW (1) TWI289566B (no)
WO (1) WO2001042262A2 (no)
ZA (1) ZA200203799B (no)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1558911B (zh) * 2001-09-07 2010-05-12 阿尔开密亚有限公司 合成肝素五糖
AU2003251869A1 (en) 2002-07-15 2004-02-02 Merck & Co., Inc. Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes
EP1554280B1 (en) 2002-10-07 2007-08-15 Merck & Co., Inc. Antidiabetic beta-amino heterocyclic dipeptidyl peptidase inhibitors
WO2004043940A1 (en) 2002-11-07 2004-05-27 Merck & Co., Inc. Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
WO2004064778A2 (en) 2003-01-17 2004-08-05 Merck & Co. Inc. 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
JP2006516573A (ja) 2003-01-31 2006-07-06 メルク　エンド　カムパニー　インコーポレーテッド 糖尿病の治療および予防のためのジペプチジルペプチダーゼ阻害薬としての３−アミノ−４−フェニルブタン酸誘導体
AU2004240563A1 (en) 2003-05-14 2004-12-02 Merck & Co., Inc. 3-amino-4-phenylbutanoic acid derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
CN1798556A (zh) 2003-06-06 2006-07-05 麦克公司 作为治疗或者预防糖尿病的二肽基肽酶抑制剂的稠合吲哚
CN1809544A (zh) 2003-06-17 2006-07-26 麦克公司 作为二肽基肽酶抑制剂用于治疗或预防糖尿病的环己基甘氨酸衍生物
CA2533893A1 (en) 2003-07-31 2005-02-10 Merck & Co., Inc. Hexahydrodiazepinones as dipeptidyl peptidase-iv inhibitors for the treatment or prevention of diabetes
EP1574516A1 (en) * 2004-03-05 2005-09-14 Sanofi-Aventis Antithrombotic compound
TW200621794A (en) * 2004-10-06 2006-07-01 Akzo Nobel Nv Pulmonary administration of an antithrombotic compound
TWI403334B (zh) * 2004-12-23 2013-08-01 Merck Sharp & Dohme 包含生物素殘基之抗血栓雙重抑制劑
TWI376234B (en) 2005-02-01 2012-11-11 Msd Oss Bv Conjugates of a polypeptide and an oligosaccharide
MY145269A (en) * 2005-10-10 2012-01-13 Organon Nv Antithrombotic dual inhibitors comprising a biotin label
CA2784529C (en) 2009-12-18 2018-05-22 Catalent France Beinheim Sa Pharmaceutical oral dosage form containing a synthetic oligosaccharide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4115468A1 (de) * 1991-05-11 1992-11-12 Behringwerke Ag Amidinophenylalaninderivate, verfahren zu deren herstellung, deren verwendung und diese enthaltende mittel als antikoagulantien
DE4206858A1 (de) * 1992-03-05 1993-09-09 Behringwerke Ag Glycopeptid-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische mittel
FR2704226B1 (fr) * 1993-04-22 1995-07-21 Sanofi Elf 3-desoxy oligosaccharides, leurs procedes de preparation et les compositions pharmaceutiques qui les contiennent.
NZ264340A (en) * 1993-09-01 1995-04-27 Akzo Nobel Nv Bisconjugate comprising two saccharides and a spacer, use in pharmaceutical compositions
IL126893A (en) * 1997-11-19 2003-05-29 Akzo Nobel Nv Sulfated pentasaccharide derivatives and pharmaceutical compositions containing them
ATE405580T1 (de) * 1998-06-17 2008-09-15 Organon Nv Antithrombotische verbindungen

Also Published As

Publication number Publication date
BR0016217A (pt) 2002-09-10
SK7942002A3 (en) 2002-09-10
IL149628A0 (en) 2002-11-10
CZ20021958A3 (cs) 2002-08-14
JP4820517B2 (ja) 2011-11-24
JP2003520208A (ja) 2003-07-02
HK1047593A1 (zh) 2003-02-28
CZ303385B6 (cs) 2012-08-29
PE20010935A1 (es) 2001-09-20
IL149628A (en) 2010-04-29
WO2001042262A2 (en) 2001-06-14
TWI289566B (en) 2007-11-11
RU2266913C2 (ru) 2005-12-27
US6875755B2 (en) 2005-04-05
AU2003801A (en) 2001-06-18
HUP0203471A3 (en) 2003-03-28
PL202840B1 (pl) 2009-07-31
NO323059B1 (no) 2006-12-27
HUP0203471A2 (hu) 2003-02-28
CA2393042A1 (en) 2001-06-14
PL355484A1 (en) 2004-05-04
CN1407989A (zh) 2003-04-02
AU781846B2 (en) 2005-06-16
SK287682B6 (sk) 2011-06-06
KR20020070988A (ko) 2002-09-11
CN1195767C (zh) 2005-04-06
KR100776607B1 (ko) 2007-11-16
AR026726A1 (es) 2003-02-26
EP1237897A2 (en) 2002-09-11
NO20022689D0 (no) 2002-06-06
NZ519100A (en) 2004-09-24
US20030114361A1 (en) 2003-06-19
WO2001042262A3 (en) 2001-12-13
CA2393042C (en) 2011-06-28
CO5251449A1 (es) 2003-02-28
EP1237897B1 (en) 2015-01-14
ZA200203799B (en) 2003-10-29

Similar Documents

Publication Publication Date Title
EE200100502A (et) Ühendid
ATA51899A (de) Handstempel
EE200200224A (et) Uudsed ühendid
ATE357433T1 (de) 4-pyrimidinyl-n-acyl-l-phenylanine
ATE297895T1 (de) 4-pyridinyl-n-acyl-l-phenylalanine
DE60015794D1 (de) Kompositverschlusskappe
DK1087992T3 (da) Antithrombotiske forbindelser
NO20022689D0 (no) Antitrombotisk forbindelse
NO20021815D0 (no) Forbindelse
NO20013769L (no) Kalsilytiske forbindelser
NO20020466L (no) Kalsilytiske forbindelser
ID28065A (id) Rakitan engsel
NO20014262D0 (no) Tiazoloindolinon-forbindelser
FI19992274L (fi) Liitosyhde
ATE440824T1 (de) Nitro-sulfobenzamide
DE10082008D2 (de) Ausbeulgerät
ATE269311T1 (de) Benzoylpyridazine
ID29984A (id) Senyawa-senyawa bis-stirilbifenil
FR2800187B1 (fr) Souris-bagues
ATA107599A (de) Heizwasserbereiter
NO991585D0 (no) Trekkanordning
AT500658A3 (de) Isolierplatte
ATA732000A (de) Kachelofen
ITMO990004A0 (it) Attacco conometrico
ITMI991892A0 (it) Nessuna

Legal Events

Date Code Title Description
CHAD Change of the owner's name or address (par. 44 patent law, par. patentforskriften)

Owner name: MERCK SHARP & DOHME BV, NL

MM1K Lapsed by not paying the annual fees